Ganesh Asaithambi1, Xin Tong2, Sallyann M Coleman King2, Mary G George2. 1. Department of Neurosciences, Allina Health United Hospital, St. Paul, Minnesota, USA. 2. Division of Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
BACKGROUND: Presentation with mild symptoms is a common reason for intravenous thrombolysis (IVT) nonuse among acute ischemic stroke (AIS) patients. We examined the impact of IVT on the outcomes of mild AIS over time. METHODS: Using the Paul Coverdell National Stroke Program data, we examined trends in IVT utilization from 2010 to 2019 among AIS patients presenting with National Institutes of Health Stroke Scale (NIHSS) scores ≤5. Outcomes adjudicated included rates of discharge to home and ability to ambulate independently at discharge. We used generalized estimating equation models to examine the effect of IVT on outcomes of AIS patients presenting with mild symptoms and calculated adjusted odds ratio (AOR) with 95% confidence intervals (CI). RESULTS: During the study period, 346,762 patients presented with mild AIS symptoms. Approximately 6.2% were treated with IVT. IVT utilization trends increased from 3.7% in 2010 to 7.7% in 2019 (p < 0.001). Patients treated with IVT had higher median NIHSS scores upon presentation (IVT 3 [2, 4] vs. no IVT 2 [0, 3]). Rates of discharge to home (AOR 2.06, 95% CI: 1.99-2.13) and ability to ambulate at time of discharge (AOR 1.82, 95% CI: 1.76-1.89) were higher among those treated with IVT. CONCLUSION: There was an increased trend in IVT utilization among AIS patients presenting with mild symptoms. Utilization of IVT increased the odds of being discharged to home and the ability to ambulate at discharge independently in patients with mild stroke.
BACKGROUND: Presentation with mild symptoms is a common reason for intravenous thrombolysis (IVT) nonuse among acute ischemic stroke (AIS) patients. We examined the impact of IVT on the outcomes of mild AIS over time. METHODS: Using the Paul Coverdell National Stroke Program data, we examined trends in IVT utilization from 2010 to 2019 among AIS patients presenting with National Institutes of Health Stroke Scale (NIHSS) scores ≤5. Outcomes adjudicated included rates of discharge to home and ability to ambulate independently at discharge. We used generalized estimating equation models to examine the effect of IVT on outcomes of AIS patients presenting with mild symptoms and calculated adjusted odds ratio (AOR) with 95% confidence intervals (CI). RESULTS: During the study period, 346,762 patients presented with mild AIS symptoms. Approximately 6.2% were treated with IVT. IVT utilization trends increased from 3.7% in 2010 to 7.7% in 2019 (p < 0.001). Patients treated with IVT had higher median NIHSS scores upon presentation (IVT 3 [2, 4] vs. no IVT 2 [0, 3]). Rates of discharge to home (AOR 2.06, 95% CI: 1.99-2.13) and ability to ambulate at time of discharge (AOR 1.82, 95% CI: 1.76-1.89) were higher among those treated with IVT. CONCLUSION: There was an increased trend in IVT utilization among AIS patients presenting with mild symptoms. Utilization of IVT increased the odds of being discharged to home and the ability to ambulate at discharge independently in patients with mild stroke.
Authors: Adnan I Qureshi; Saqib A Chaudhry; Biggya L Sapkota; Gustavo J Rodriguez; M Fareed K Suri Journal: Arch Phys Med Rehabil Date: 2012-03-21 Impact factor: 3.966
Authors: Xin Tong; Jennifer L Wiltz; Mary G George; Erika C Odom; Sallyann M Coleman King; Tiffany Chang; Xiaoping Yin; Robert K Merritt Journal: Circ Cardiovasc Qual Outcomes Date: 2018-12
Authors: Pooja Khatri; Dawn O Kleindorfer; Sharon D Yeatts; Jeffrey L Saver; Steven R Levine; Patrick D Lyden; Charles J Moomaw; Yuko Y Palesch; Edward C Jauch; Joseph P Broderick Journal: Stroke Date: 2010-09-02 Impact factor: 7.914
Authors: Joshua Z Willey; Pooja Khatri; Jane C Khoury; José G Merino; Andria L Ford; Natalia S Rost; Nicole R Gonzales; Latisha K Ali; Brett C Meyer; Joseph P Broderick Journal: J Stroke Cerebrovasc Dis Date: 2011-12-15 Impact factor: 2.136
Authors: Hamidreza Saber; Kasra Khatibi; Viktor Szeder; Satoshi Tateshima; Geoffrey P Colby; May Nour; Reza Jahan; Gary Duckwiler; David S Liebeskind; Jeffrey L Saver Journal: Stroke Date: 2020-10-21 Impact factor: 7.914
Authors: Steven R Levine; Pooja Khatri; Joseph P Broderick; James C Grotta; Scott E Kasner; Doojin Kim; Brett C Meyer; Peter Panagos; Jose Romano; Phillip Scott Journal: Stroke Date: 2013-07-11 Impact factor: 7.914
Authors: Pooja Khatri; Dawn O Kleindorfer; Thomas Devlin; Robert N Sawyer; Matthew Starr; Jennifer Mejilla; Joseph Broderick; Anjan Chatterjee; Edward C Jauch; Steven R Levine; Jose G Romano; Jeffrey L Saver; Achala Vagal; Barbara Purdon; Jenny Devenport; Andrey Pavlov; Sharon D Yeatts Journal: JAMA Date: 2018-07-10 Impact factor: 56.272